ThinkEquity Starts Impax Laboratories (IPXL) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts IPXL Hot Sheet
Price: $18.30 --0%
Rating Summary:
8 Buy, 15 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 12 | New: 3
Rating Summary:
8 Buy, 15 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 12 | New: 3
Join SI Premium – FREE
ThinkEquity initiates coverage on Impax Laboratories (NASDAQ: IPXL) with a Buy. PT $25.00.
For more ratings news on Impax Laboratories click here and for the rating history of Impax Laboratories click here.
Shares of Impax Laboratories closed at $18.79 yesterday.
For more ratings news on Impax Laboratories click here and for the rating history of Impax Laboratories click here.
Shares of Impax Laboratories closed at $18.79 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Roth/MKM Starts AIRO Group (AIRO) at Buy
- H.C. Wainwright Assumes Nkarta Inc. (NKTX) at Buy
- Nomura/Instinet Starts Page Industries Ltd. (PAG:IN) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
ThinkEquitySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
